Integrated Wealth Concepts’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.78M	Buy	5,374 +1,134	+27%	+$386K	0.01%	806
2025 Q4	$1.69M	Sell	4,240 -396	-9%	-$175K	0.02%	576
2025 Q3	$2.11M	Buy	4,636 +1,191	+35%	+$485K	0.02%	651
2025 Q2	$1.12M	Buy	3,445 +706	+26%	+$195K	0.01%	862
2025 Q1	$740K	Buy	2,739 +227	+9%	+$58.3K	0.01%	966
2024 Q4	$591K	Buy	2,512 +176	+8%	+$46.3K	0.01%	1051
2024 Q3	$642K	Buy	2,336 +22	+1%	+$5.73K	0.01%	980
2024 Q2	$562K	Sell	2,314 -6	-0.3%	-$947	0.01%	998
2024 Q1	$347K	Buy	2,320 +31	+1%	+$5.17K	0.01%	1239
2023 Q4	$438K	Buy	2,289 +15	+0.7%	+$2.56K	0.01%	1056
2023 Q3	$403K	Buy	2,274 +3	+0.1%	+$572	0.01%	1073
2023 Q2	$431K	Sell	2,271 -135	-6%	-$26.8K	0.01%	1053
2023 Q1	$482K	Buy	+2,406	New	+$506K	0.01%	864